Peripheral blood gene expression profiling in rheumatoid arthritis

Genes and Immunity

Volumn 6, Issue 5, 2005, Pages 388-397

  Batliwalla, F M ^a,b   Baechler, E C ^c   Xiao, X ^a,b   Li, W ^b   Balasubramanian, S ^c   Khalili, H ^a,b   Damle, A ^a,b   Ortmann, W A ^c   Perrone, A ^d   Kantor, A B ^d   Gulko, P S ^a,b   Kern, M ^a,b   Furie, R ^b   Behrens, T W ^c   Gregersen, Peter K ^a,b  

^a North Shore Long Island Jewish Research Institute ^*  (United States)

^b NSUH CUMC   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d SurroMed Inc   (United States)

Author keywords

Gene expression; Microarray; Monocytes; Peripheral blood mononuclear cells; Rheumatoid arthritis

Indexed keywords

BINDING PROTEIN; BIOLOGICAL MARKER; CALGRANULIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; AGED; ARTICLE; CELL COUNT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC RISK; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; MALE; OUTCOMES RESEARCH; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SAMPLE SIZE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 30744449552     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364209     Document Type: Article

References (46)

1. Gregersen PK. Teasing apart the complex genetics of human autoimmunity: lessons from rheumatoid arthritis. Clin Immunol 2003; 107: 1-9.
2. Gulko PS, Winchester RJ. Rheumatoid arthritis. In: Frank Austen K, Frank MM, Atkinson JP, Cantor H (eds). Samter's Immunologic Diseases. Lippincot Williams and Wilkins: Philadelphia, PA, 1995, pp 427-463.
3. Weinblatt ME, Kremer JM, Bankhurst AD et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999; 340: 253-259.
4. Lipsky PE, van der Heijde DM, St Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000; 343: 1594-1602.
5. Staudt LM. Gene expression profiling of lymphoid malignancies. Annu Rev Med 2002; 53: 303-318.
6. Baechler EC, Batliwalla FM, Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610-2615.
7. Finnin M, Hamilton JA, Moss ST. Characterization of a CSF-induced proliferating subpopulation of human peripheral blood monocytes by surface marker expression and cytokine production. J Leukoc Biol 1999; 66: 953-960.
8. Lohn M, Mueller C, Langner J. Cell cycle retardation in monocytoid cells induced by aminopeptidase N (CD13). Leuk Lymphoma 2002; 43: 407-413.
9. Jawaheer D, Seldin MF, Amos CI et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001; 68: 927-936.
10. Jawaheer D, Seldin MF, Amos CI, et al, North American Rheumatoid Arthritis Consortium. Screening the genome for rheumatoid arthritis susceptibility genes: A replication study and combined analysis of 512 multicase families. Arthritis Rheum 2003; 48: 906-916.
11. Harris ED. Clinical features of rheumatoid arthritis. In: Kelley WN, Ruddy S, Harris Jr ED, Sledge CB (eds). Textbook of Rheumatology, 5th edn. WB Saunders Company: Philadelphia, 1997, pp 898-932.
12. Fuchs HA, Sergent JS. Rheumatoid arthritis: The clinical picture. In: Koopman WJ (ed). Arthritis and Allied Conditions, 13th edn. Williams and Wilkins: Baltimore, 1997, pp 1041-1070.
13. Bovin LF, Rieneck K, Workman C et al. Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. Immunol Lett 2004; 93: 217-226.
14. Kawanaka N, Yamamura M, Aita T et al. CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 2002; 46: 2578-2586.
15. Cairns AP, Crockard AD, Bell AL. The CD14+ CD16+ monocyte subset in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol Int 2002; 21: 189-192.
16. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
17. Abrahams VM, Cambridge G, Lydyard PM, Edwards JC. Induction of tumor necrosis factor alpha production by adhered human monocytes: A key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum 2000; 43: 608-616.
18. Stuhlmuller B, Ungethum U, Scholze S et al. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 775-790.
19. Hirohata S, Yanagida T, Hashimoto H, Tomita T, Ochi T. Suppressive influences of methotrexate on the generation of CD14(+) monocyte-lineage cells from bone marrow of patients with rheumatoid arthritis. Clin Immunol 1999; 91: 84-89.
20. van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, Pieterman E, Breedveld FC, Verweij CL. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun 2003; 4: 187-196.
21. Bennett L, Palucka AK, Arce E et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 97: 711-723.
22. Crow MK, Wohlgemuth J. Microarray analysis of gene expression in lupus. Arthritis Res Ther 2003; 5: 279-287.
23. Maas K, Chan S, Parker J et al. Cutting edge: Molecular portrait of human autoimmune disease. J Immunol 2002; 169: 5-9.
24. Bomprezzi R, Ringner M, Kim S et al. Gene expression profile in multiple sclerosis patients and healthy controls: Identifying pathways relevant to disease. Hum Mol Genet 2003; 12: 2191-2199.
25. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004; 50: 3762-3771.
26. Hofmann MA, Drury S, Hudson BI et al. RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response. Genes Immun 2002; 3: 123-135.
27. Rouleau P, Vandal K, Ryckman C et al. The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. Clin Immunol 2003; 107: 46-54.
28. Foell D, Kucharzik T, Kraft M et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003; 52: 847-853.
29. Schilling S, Niestroj AJ, Rahfeld JU et al. Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators. J Biol Chem 2003; 278: 49773-49779.
30. Nishida K, Hirano T. The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci 2003; 94: 1029-1033.
31. Nishida K, Wang L, Morii E et al. Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. Blood 2002; 99: 1866-1869.
32. Arnaud M, Cronin C, Deon C, Loyaux D, Bertoglio J. Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation. J Immunol 2004; 173: 3962-3971.
33. Begovich AB, Carlton VE, Honigberg LA et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-337.
34. Lee AT, Li W, Liew A et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun 2005; 6: 129-133.
35. Baechler EC, Batliwalla FM, Karypis G et al. Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun 2004; 5: 347-353.
36. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.
37. Dyke GV, Patterson HD. Analysis of factorial arrangement when the data are proportional. Biometrics 1952; 8: 1-12.
38. Eilers PH, Boer JM, van Ommen GJ, van Houwelingen HC. Classification of microarray data with penalized logistic regression. Proc SPIE 2001; 4266: 187-198.
39. Li W, Yang Y. How many genes are needed for a discriminant microarray data analysis. In: Lin SM, Johnson KF (eds). Methods of Microarray Data Analysis. Kluwer Academic: Boston/Dordrecht/London, 2002, pp 137-149.
40. van't Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536.
41. Walton ID, Dietz LJ, Frenzel G et al. Microvolume laser scanning cytometry platform for biological marker discovery. Proc SPIE Int Soc Opt Eng IBOS Soc Photo-Opt Instrum Eng 2000; 3926: 192-201.
42. Kantor AB, Alters SE, Cheal K, Dietz LJ. Immune systems biology: immunoprofiling of cells and molecules. BioTechniques 2004; 36: 520-524.
43. Kantor AB, Wang W, Lin H et al. Biomarker discovery by comprehensive phenotyping for 2 autoimmune diseases. Clin Immunol 2004; 111: 186-195.
44. Mujumdar RB, Ernst LA, Mujumdar SR, Lewis CJ, Waggoner AS. Cyanine dye labeling reagents: Sulfoindocyanine succinimidyl esters. Bioconjug Chem 1993; 4: 105-111.
45. Roederer M, Kantor AB, Parks DR, Herzenberg LA. Cy7PE and Cy7APC: Bright new probes for immunofluorescence. Cytometry 1996; 24: 191-197.
46. Beavis AJ, Pennline KJ. Allo-7: A new fluorescent tandem dye for use in flow cytometry. Cytometry 1996; 24: 390-395.